<乌鸦传媒>SABR Offers New Hope for Older Patients With Inoperable Kidney Cancer Phase II study shows 100% local control and cancer-specific survival after more than 3 years Oct 01, 2023
<乌鸦传媒>SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
<乌鸦传媒>Individualized SABR for Lung Tumors Yields Low Recurrence Rates Strategy also results in low rates of severe toxic effects Sep 14, 2023
<乌鸦传媒>IMRT Best for Locally Advanced NSCLC, Study Suggests Technique reduces risk of severe lung toxicity and radiation to the heart compared with 3D-CRT Sep 13, 2023
<乌鸦传媒>MR-Guided Adaptive SBRT Tied to Reduced Side Effects in Prostate Cancer However, this technique requires more time and resources than standard techniques Jul 24, 2023
<乌鸦传媒>Immunotherapy Added to SABR Improves Event-Free Survival in Early NSCLC Approach is "potentially practice-changing," editorialist says Jul 20, 2023
<乌鸦传媒>Oral Cancer Patients Face Worse Outcomes With Delayed Radiation Therapy Failure to initiate adjuvant radiation therapy within 6 weeks tied to survival rates Jul 10, 2023
<乌鸦传媒>Primary Surgery vs Radiation in Oropharyngeal Cancer: Does One Come Out a Winner? Higher short-term dysphagia risk with surgery, but RT/CRT had worse 5-year OS Jul 09, 2023
<乌鸦传媒>IMRT Dosing Strategy Eases Dysphagia in Head and Neck Cancer A new standard for patients receiving intensity-modulated radiotherapy for pharyngeal cancers? Jul 07, 2023
<乌鸦传媒>Skipping Radiotherapy 'Seems Safe' for PMBCL Patients in Remission PET-negative patients after chemoimmunotherapy fared well with observation alone Jun 07, 2023
<乌鸦传媒>Omitting RT Safe in Many Locally Advanced Rectal Cancers Most intermediate-risk cases can be cured without pelvic radiation, says investigator Jun 05, 2023
<乌鸦传媒>Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancer "Expensive and intensive" process does not translate into clinical benefit, researchers conclude Jun 01, 2023
<乌鸦传媒>Dual-Chamber Leadless Pacemaker Impresses in Safety-and-Performance Study Device provided atrial pacing, reliable atrioventricular synchrony for 3 months post-implantation May 21, 2023
<乌鸦传媒>PCI 'Roadmap' for the Coronary Tree Cuts Contrast Use Tool could hold promise for reducing acute kidney injury risk May 19, 2023
<乌鸦传媒>ChatGPT Passes Board Exam Here's how two versions of the chatbot performed on mock radiology boards May 16, 2023
<乌鸦传媒>Implanted Ultrasound Device Opening Blood-Brain Barrier Promising in Brain Tumors Device allows delivery of more potent chemotherapies to patients with glioblastomas May 03, 2023
<乌鸦传媒>Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
<乌鸦传媒>Pulsed Field Afib Ablation Hits Endpoints in Pivotal Trial Technology appears durable in most patients Mar 08, 2023
<乌鸦传媒>'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancer Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
<乌鸦传媒>Immediate Complete Revascularization Non-Inferior to Staged Procedure Patients with ACS and multivessel disease saw multiple outcome benefits in BIOVASC trial Mar 05, 2023
<乌鸦传媒>Safe to Omit RT After Lumpectomy in Certain Older Breast Cancer Patients Radiotherapy reduced local recurrence, but showed no effect on OS, distant recurrence Feb 15, 2023
<乌鸦传媒>Perioperative Chemo Matches Multimodal Tx for Locally Advanced Esophageal/GEJ Cancer Nearly identical 3-year survival, questioning the need for radiotherapy before surgery Jan 20, 2023
<乌鸦传媒>MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
<乌鸦传媒>Genomic Assay May Pinpoint Who Can Skip RT After Breast-Conserving Surgery Patients categorized as low risk with 16-gene signature showed no significant benefit with RT Jan 06, 2023
<乌鸦传媒>Optimizing Treatment for Older Patients With HR+ Low-Risk Breast Cancer Five days of radiotherapy, five years of hormonal therapy, or somewhere in between? Jan 05, 2023
<乌鸦传媒>Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
<乌鸦传媒>RT After Breast-Conserving Surgery Shows No Survival Advantage Decades Later But "that's not the intent of radiation therapy," says outside expert Nov 18, 2022
<乌鸦传媒>Treatment De-Escalation Shows Promise in Testicular Cancer Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022
<乌鸦传媒>Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone Oct 27, 2022
<乌鸦传媒>Ablative MR-Guided RT Shows Promise in Pancreatic Cancer SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data Oct 27, 2022
<乌鸦传媒>Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancer Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy Oct 26, 2022
<乌鸦传媒>Radiation for Asymptomatic Bone Metastases May Improve Cancer Survival Fewer skeletal events, less pain unexpectedly followed by longer life Oct 26, 2022
<乌鸦传媒>Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
<乌鸦传媒>Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
<乌鸦传媒>New Standard-of-Care Therapy for Advanced Liver Cancer Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
<乌鸦传媒>Rapid Radiotherapy Technique Shows Promise in First Human Trial FLASH relieved pain in most patients with bone metastases, with few side effects Oct 24, 2022
<乌鸦传媒>High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL Patients report better urinary and bowel function outcomes Oct 24, 2022
<乌鸦传媒>Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancer "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
<乌鸦传媒>Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggests Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
<乌鸦传媒>This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancer Risk is low but appears to have modifiable components Oct 13, 2022
